ArticleCancers2019

ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin.

Ciro Francesco Ruggiero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.